NCT06115668

Brief Summary

The aim of this study is to evaluate the effectiveness of intraoperative individualized positive end-expiratory pressure (PEEPIND) titration, compared to fixed positive end-expiratory pressure of 5 cmH2O, on oxygenation, hemodynamic variables, and early postoperative complications in obese patients undergoing laparoscopic bariatric surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 3, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

November 5, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

5 months

First QC Date

October 30, 2023

Last Update Submit

November 5, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intraoperative oxygenation

    Intraoperative oxygenation which will be assessed by P/F ratio (the ratio of arterial oxygen partial pressure (PaO2 in mmHg) to fractional inspired oxygen (FiO2 expressed as a fraction, not a percentage). PaO2/FiO2: will be measured at before induction of anesthesia, immediately after intubation, after PEEP titration, one hour after pneumoperitoneum, before extubation, one hour after extubation

    One hour after extubation

Secondary Outcomes (7)

  • Mean arterial pressure(MAP)

    One hour after extubation

  • Heart rate(HR)

    One hour after extubation

  • Volume of total fluid infusion

    Till the end of surgery

  • Dosage of vasopressors

    Till the end of surgery

  • Lung ultrasound scores

    12 hours postoperatively

  • +2 more secondary outcomes

Study Arms (2)

Positive end-expiratory pressure 5 (PEEP 5)

ACTIVE COMPARATOR

Patients will receive fixed positive end-expiratory pressure(= 5 cmH2O) as a control group

Other: Positive end-expiratory pressure 5 (PEEP 5)

Individualized positive end-expiratory pressure (PEEPIND)

EXPERIMENTAL

Patients who will receive the individualized positive end-expiratory pressure.

Other: Individualized positive end-expiratory pressure (PEEPIND)

Interventions

Fixed positive end-expiratory pressure of 5 cmH2O will be maintained throughout the duration of surgery

Positive end-expiratory pressure 5 (PEEP 5)

Patients will receive the individualized positive end-expiratory pressure. Titration process will be started after establishment of pneumoperitoneum: setting the initial PEEP to 5 cmH2O, then increasing positive end-expiratory pressure (PEEP)according to the gradient of 2 cmH2O every 3 min, calculating static compliance (Cstat) according to the formula: \[Cstat = VT/Pplat - PEEP\] (Pplat = plateau pressure), then gradually increasing positive end-expiratory pressure , until the calculated Cstat shows a downward trend, set its previous PEEP (corresponding to PEEP for high Cstat) as the optimal PEEPIND for this patient. The highest PEEP is limited to 20 cmH2O

Individualized positive end-expiratory pressure (PEEPIND)

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age from 21 to 60 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status class I-III
  • Patients who are scheduled for elective laparoscopic bariatric surgery under general anesthesia.

You may not qualify if:

  • Patients who are unwilling to participate in the study
  • Actively smokers.
  • Patients who had a history of Chronic obstructive pulmonary disease or bronchial asthma.
  • Patients who are receiving renal replacement therapy prior to surgery.
  • Patients who had a history of heart failure.
  • Pregnant.
  • Patients who have allergies to any drug used in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

RECRUITING

Central Study Contacts

Heba Z Khattab, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine

Study Record Dates

First Submitted

October 30, 2023

First Posted

November 3, 2023

Study Start

November 5, 2023

Primary Completion

April 1, 2024

Study Completion

April 1, 2024

Last Updated

November 7, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations